American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update
Errata to this article were published (Endocr Pract, Sep 2023 ↗ · Dec 2023 ↗)
Methodological detailstask force of medical experts, update of the 2020 American Association of Clinical Endocrinology (AACE) Comprehensive Type 2 Diabetes Management Algorithm
- Task force of medical experts
- Update of the 2020 AACE Comprehensive Type 2 Diabetes Management Algorithm
Recommendations
As issued by the authors
Lifestyle modification and treatment of overweight/obesity are key pillars in the management of prediabetes and DM
Appropriate management of atherosclerotic risk factors of dyslipidemia and hypertension is important
A complication-centric approach, beyond glucose levels, frames decisions on first-line pharmacologic choices
Access/cost of medications are factors related to health equity to consider in clinical decision-making
New sections: Profiles of Weight-Loss Medications; Vaccine Recommendations for Persons with DM (summarizing CDC Advisory Committee on Immunization Practices recommendations)
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →